Literature DB >> 12524373

Vascular endothelial growth factor in patients with high-altitude pulmonary edema.

Masayuki Hanaoka1, Yunden Droma, Atsuhiko Naramoto, Takayuki Honda, Toshio Kobayashi, Keishi Kubo.   

Abstract

To examine the role of VEGF in the pathogenesis of high-altitude pulmonary edema (HAPE), we measured the concentrations of VEGF in venous serum and bronchoalveolar lavage fluid in patients with HAPE and in healthy volunteers. The VEGF in venous serum of the patients was normal at admission and significantly increased at recovery. Similarly, the VEGF in bronchoalveolar lavage fluid of the patients was increased at recovery compared with admission, but values at both admission and recovery were significantly lower than those of the controls. The present finding suggests that VEGF probably is destroyed in the lung of HAPE, and it appears less likely to have a critical part in the pathogenesis of HAPE but has rather an important role in the repair process for the impaired cell layer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12524373     DOI: 10.1152/japplphysiol.00575.2002

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  18 in total

Review 1.  Virus interactions with endothelial cell receptors: implications for viral pathogenesis.

Authors:  Nadine A Dalrymple; Erich R Mackow
Journal:  Curr Opin Virol       Date:  2014-07-24       Impact factor: 7.090

2.  VEGF levels in the alveolar compartment do not distinguish between ARDS and hydrostatic pulmonary oedema.

Authors:  L B Ware; R J Kaner; R G Crystal; R Schane; N N Trivedi; D McAuley; M A Matthay
Journal:  Eur Respir J       Date:  2005-07       Impact factor: 16.671

Review 3.  Vascular endothelial growth factor (VEGF) in acute lung injury (ALI) and acute respiratory distress syndrome (ARDS): paradox or paradigm?

Authors:  A R L Medford; A B Millar
Journal:  Thorax       Date:  2006-07       Impact factor: 9.139

4.  Hantavirus interferon regulation and virulence determinants.

Authors:  Erich R Mackow; Nadine A Dalrymple; Velasco Cimica; Valery Matthys; Elena Gorbunova; Irina Gavrilovskaya
Journal:  Virus Res       Date:  2014-01-08       Impact factor: 3.303

5.  Sorafenib-induced interstitial pneumonitis in a patient with hepatocellular carcinoma: a case report.

Authors:  Hyung-Joon Myung; Sook-Hyang Jeong; Jin-Wook Kim; Hee-Sup Kim; Je-Hyuck Jang; Ho Il Yoon; Jae-Sung Kim
Journal:  Gut Liver       Date:  2010-12-17       Impact factor: 4.519

6.  Vascular endothelial growth factor gene polymorphism and acute respiratory distress syndrome.

Authors:  A R L Medford; L J Keen; J L Bidwell; A B Millar
Journal:  Thorax       Date:  2005-03       Impact factor: 9.139

7.  Vascular Endothelial Growth Factor as a Prognostic Parameter in Subjects with "Plateau Red Face".

Authors:  Lan Ma; Ying Chen; Guoen Jin; Yingzhong Yang; Qin Ga; Ri-Li Ge
Journal:  High Alt Med Biol       Date:  2015-04-28       Impact factor: 1.981

8.  VEGF in the lung: a role for novel isoforms.

Authors:  Julia Varet; Samantha K Douglas; Laura Gilmartin; Andrew R L Medford; David O Bates; Steven J Harper; Ann B Millar
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2010-03-12       Impact factor: 5.464

9.  Genotypes and haplotypes of the VEGF gene are associated with higher mortality and lower VEGF plasma levels in patients with ARDS.

Authors:  R Zhai; M N Gong; W Zhou; T B Thompson; P Kraft; L Su; D C Christiani
Journal:  Thorax       Date:  2007-02-08       Impact factor: 9.139

10.  Hypoxia induces permeability and giant cell responses of Andes virus-infected pulmonary endothelial cells by activating the mTOR-S6K signaling pathway.

Authors:  Irina N Gavrilovskaya; Elena E Gorbunova; Erich R Mackow
Journal:  J Virol       Date:  2013-09-25       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.